Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03198598 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Yoga Practice in Multiple Sclerosis Patients: a Multidimensional Approach

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 26, 2022 to Dec 26, 2026v6
  2. Primary completion date: May 26, 2021 to Dec 26, 2022
    • Study completion date: Jun 26, 2021 to Dec 26, 2022
    v5
  3. Primary completion date: May 26, 2020 to May 26, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 26, 2020 to Jun 26, 2021
    • Site details revised
    v4
  4. Primary completion date: Mar 26, 2019 to May 26, 2020
    • Study completion date: Jun 26, 2019 to Jun 26, 2020
    v3
  5. Primary completion date: Jun 26, 2018 to Mar 26, 2019v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study the investigators will evaluate the effects of yoga practice on multiple sclerosis patients and healthy controls for fatigue, quality of life, movement, cognition, brain activity, self-efficacy, stress, anxiety, depression, affective states and immunological response. To investigate the effects of yoga training delivered by a yoga instructor or through a smartphone application, the investigators will use a multidimensional approach that comprises of: evaluation of neuropsychological, quality of life and affective aspects, structural and functional magnetic resonance imaging, functional near infrared spectroscopy (fNIRS) combined with movement analysis (gait, strength, balance etc.) and analysis of the immune response.
Trial Details
NCT Number NCT03198598
Lead Sponsor Hospital Israelita Albert Einstein
Conditions
(from sponsor)		 Multiple Sclerosis
Related terms Multiple Sclerosis
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov